Micro Total Analysis Systems For Cell Biology and Biochemical Assays

Department of Chemistry, University of North Carolina, Chapel Hill, North Carolina 27599, United States.
Analytical Chemistry (Impact Factor: 5.64). 10/2011; 84(2):516-40. DOI: 10.1021/ac202611x
Source: PubMed


Novel applications of micro total analysis systems (μTAS) are addressing fundamental biological questions, fabricating new biomedical reagents, and developing cell and biochemical assays. These efforts impact progress in all areas of μTAS from materials to fluidic handling as well as detection and external control systems. Three areas show the greatest current and potential impact on the biomedical sciences: improvements in device fabrication and operation, development of enabling technologies, and advancements at the interface with biology (Figure 1). The range of materials from which devices can be fabricated has expanded considerably and now includes paper, fabric and thread, and a multitude of polymers as well as more conventional materials. Thus device substrates and component materials suitable for nearly all biological applications are readily available. Devices are also becoming increasingly integrated with advancements in sampling handling and preparation, a key and first step in any biological analysis. Another growing area focuses on modular components that can be mixed and matched on-demand and applied to many different assays, so-called programmable microfluidics. This development should enhance the rate at which new bioassays are generated as well as customize existing experimental protocols. A second area of rapid advancement has been the development new technologies that enable assays that cannot be efficiently performed by any method except μTAS. Novel analyses of single cells are enabled due to effective manipulation of picoliter-scale volumes. Synthesis and screening of large-scale libraries has become increasingly feasible due to the fast processing speeds and combinatorial mixing of reagents provided by lab-on-chip systems. Increased automation within a completely contained system has now begun to provide some of the first true μTAS diagnostic devices for clinical medicine. The third area in which μTAS has begun to yield high dividends is the interfacing of living entities with microdevices to create biological communities including tissues and organs on-chip. Control of cell placement in multiple dimensions has produced biological systems midway between the conventional tissue-culture dish and an intact animal. Thus the complexities of living constructs can be recreated in a controlled experimental environment permitting groundbreaking biological questions to be addressed. Application of μTAS in all of these areas continues to be highly interdisciplinary, utilizing techniques and strategies from almost every scientific field. This multidisciplinary focus insures continued relevance to the biological community as well as a bright future.


Available from: Philip Charles Gach, Jan 27, 2014

Click to see the full-text of:

Article: Micro Total Analysis Systems For Cell Biology and Biochemical Assays

6.99 MB

See full-text
  • Source
    • "In the future, such database-oriented lab-on-chip devices might grow into a new branch in the microsystems research field. Compared with the study for MicroTAS systems [29], which try to make the microdevices more and more complex [30], the database-oriented lab-on-chips will be simpler and simpler with the essential precondition of qualified detection capability, so as to reduce the cost of data acquisition in the medical investigation. This study built a model for other database-oriented lab-on-a-chip devices. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mood disorders are common mental diseases, but physiological diagnostic methods are still lacking. Since much evidence has implied a relationship between mood disorders and the protein composition of blood sera, it is conceivable to develop a serological criterion for assisting diagnosis of mood disorders, based on a correlative database with enough capacity and high quality. In this pilot study, a low-cost microfluidic microarray device for quantifying at most 384 serological biomarkers at the same time was designed for the data acquisition of the serological study. The 1,536-chamber microfluidic device was modeled on a 1,536-well microtiter plate in order to employ a common microplate reader as the detection module for measuring the chemiluminescent immunoassay tests on the chips. The microfluidic microarrays were rapidly fabricated on polymethylmethacrylate slides using carbon dioxide laser ablation, followed by effective surface treatment processing. Sixteen types of different capture antibodies were immobilized on the chips to test the corresponding hormones and cytokines. The preliminary tests indicated that the signal-to-noise ratio and the limit of detection of microfluidic microarrays have reached the level of standard ELISA tests, whereas the operation time of microfluidic microarrays was sharply reduced.
    Sensors 11/2013; 13(11):14570-82. DOI:10.3390/s131114570 · 2.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper reports the fabrication and characterization of a prototype microfluidic device that can act as a periodic beam steerer. The prototype is formed by a simple T-junction followed by a serpentine channel that allows generation of a periodical segmented flow of air and water bubbles. If light hits the channel wall with a suitable angle, it can be either transmitted or reflected by the segmented flow, giving rise to an alternating beam steerer. The duty cycle, switching frequency, and overall stability and reproducibility of this prototype system are presented and discussed.
    Microfluidics and Nanofluidics 01/2013; 16(1-2). DOI:10.1007/s10404-013-1214-9 · 2.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nitric oxide (NO) is a biologically important short-lived reactive species that has been shown to be involved in a large number of physiological processes. The production of NO is substantially increased in immune and other cell types through the upregulation of inducible nitric oxide synthase (iNOS) caused by exposure to stimulating agents such as lipopolysaccharide (LPS). NO production in cells is most frequently measured via fluorescence microscopy using diaminofluorescein-based probes. Capillary electrophoresis with laser-induced fluorescence detection has been used previously to separate and quantitate the fluorescence derivatives of NO from potential interferences in single neurons. In this paper, microchip electrophoresis (ME) coupled to laser-induced fluorescence (LIF) detection is evaluated as a method for measurement of the NO production by Jurkat cells under control and stimulating conditions. ME is ideal for such analyses due to its fast and efficient separations, low volume requirements, and ultimate compatibility with single cellchemical cytometry systems. In these studies, 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM DA) was employed for the detection ofNO, and 6-carboxyfluorescein diacetate (6-CFDA) was employed as an internal standard. Jurkat cells were stimulated using lipopolysaccharide (LPS) to produce NO, and bulk cell analysis was accomplished using ME-LIF. Stimulated cells exhibited an approximately 2.5-fold increase in intracellularNO production compared to the native cells. A NO standard prepared using diethylamine NONOate (DEA/NO) salt was used to construct a calibration curve for quantitation of NO in cell lysate. Using this calibration curve, the average intracellularNO concentrations for LPS-stimulated and native Jurkat cells were calculated to be 1.5 mM and 0.6 mM, respectively
    Analytical methods 02/2012; 4(2):414-420. DOI:10.1039/C2AY05542B · 1.82 Impact Factor
Show more